MYELOPROLIFERATIVE NEOPLASMS
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailored transplants for seniors: a smarter approach to blood cancer?
Disease control OngoingThis study looks at whether a special health check-up for older adults (age 60+) can help doctors choose the best stem cell transplant plan for blood cancers like leukemia or MDS. The goal is to lower the chance of serious side effects and improve quality of life. About 33 partic…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New combo therapy aims to fight relapsed blood cancers after transplant
Disease control OngoingThis early-phase study tests a new treatment for people whose blood cancer (like AML or MDS) has come back after a stem cell transplant. The treatment combines a special type of donor immune cell infusion with an immunotherapy drug called ipilimumab. The main goal is to find the …
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC